US biopharmaceutical company Amgen (NASDAQ:AMGN) announced on Thursday that its board of directors has declared a dividend of USD2.52 per share for the third quarter of 2026.
This amount is unchanged from the previous quarterly dividend.
Stockholders of record as of the close of business on 21 August 2026 will receive the dividend on 11 September 2026.
Valerio Therapeutics signs R&D collaboration with Abivax and outlines pipeline milestones
Labcorp declares quarterly dividend of USD0.72 per share
Aptamer Group launches Optimer-based Ebola diagnostic programme
SK bioscience to lead Gates Foundation-funded ROTOR project
Nona Biosciences and Lonza collaborate on antibody-based BBB-crossing technology for CNS diseases